Vanderbilt University School of Medicine (MD) Medicine InterviewFormat, Questions & Prep Tips

Vanderbilt's Curriculum 2.0 integrates clinical and basic science from Year 1 and expects every student to develop a scholarly thread. Why does that model suit how you learn and grow?

Tie your answer to early integration, self-directed learning, and the scholarly project requirement. Show you understand Curriculum 2.0 rather than describing a generic integrated course.

Vanderbilt is a leader in precision medicine through BioVU and the eMERGE Network. How do you see genomics changing clinical practice over your career?

Engage pharmacogenomics, polygenic risk scores, and precision oncology, but also the equity concern that biobanks have historically under-represented minority populations. Avoid treating precision medicine as a buzzword.

Tell us about a time you had to take ownership of your own learning without a clear structure. What happened?

Curriculum 2.0 rewards self-direction. Use a concrete example showing initiative, self-assessment, and the ability to seek out what you needed when no one handed it to you.

What do you want to be true about your career that has nothing to do with prestige or title?

Reveal intrinsic values: the kind of relationships, impact, or problems you want to be defined by. Vanderbilt looks for authentic motivation beyond credentials.

Tennessee has not expanded Medicaid, leaving a coverage gap. A patient in your clinic is uninsured and needs an expensive but evidence-based treatment. What do you do as her physician?

Know the Tennessee coverage gap, charity care, 340B drug pricing, and pharmaceutical patient-assistance programmes. Combine immediate problem-solving with awareness of the systemic cause.

A patient asks whether they should get a polygenic risk score for a disease that has no clear preventive treatment. How do you counsel them?

Weigh the right to know against actionability, anxiety, and insurance or psychological consequences. Vanderbilt's genomics leadership makes this concrete, so reason carefully rather than reflexively encouraging testing.

Most genomic databases over-represent people of European ancestry, which can make risk tools less accurate for others. What ethical obligations does that create for clinicians and researchers?

Address justice, the risk of widening disparities, the duty to broaden representation, and honest communication about a tool's limits. This connects directly to BioVU and equity in precision medicine.

A pharmaceutical company offers to fund a scholarly project you are excited about, but with conditions on publishing the results. How do you respond?

Engage conflict of interest, the right to publish negative findings, transparency, and academic freedom. A strong answer protects scientific integrity without rejecting all industry partnership outright.

Explain to a patient with no scientific background what a genetic test result of 'increased risk' actually means for them.

Distinguish risk from certainty, avoid jargon, and address the emotional weight of the word 'risk'. The goal is accurate understanding without inducing fatalism or false reassurance.

Describe a time you had to give honest feedback to a peer or teammate. How did you handle it?

Show empathy paired with candour, and reflect on the result. Curriculum 2.0's small-group, peer-rich environment values constructive, respectful communication.

Vanderbilt expects every student to pursue a scholarly project. What area would you investigate, and why does it matter?

Any rigorous area is welcome — basic science, health services research, medical education, informatics, or policy. Frame a genuine, answerable question rather than a broad topic, and consider the popular MSCI dual-degree path.

How can data from electronic health records, like Vanderbilt's, advance medicine — and what could go wrong?

Discuss the power of large linked datasets for discovery alongside privacy, bias, data quality, and over-reliance on imperfect records. Vanderbilt's biomedical informatics strength makes this a natural probe.

Walk me through a research or scholarly experience. What was your contribution, and what were the limits of what you found?

Separate independent thinking from supervised tasks and be honest about limitations. Methodological self-awareness signals readiness for the scholarly thread.

An uninsured patient is overwhelmed and embarrassed that she cannot afford the medication you have recommended. Speak with her.

Lead with dignity and reassurance, then problem-solve: assistance programmes, generic alternatives, social work, and follow-up. Reflect Tennessee's real coverage realities without shaming the patient.

A classmate is anxious that they are 'falling behind' in the self-directed parts of the curriculum and is considering hiding it. Talk with them.

Normalise the struggle of self-directed learning, listen first, and steer them toward faculty and wellbeing support rather than secrecy. Show peer support without taking on a role you cannot fill.

You're shown that a new risk-prediction tool performs well in one population but poorly in another. How do you interpret that, and what would you do before using it clinically?

Consider the training data's representativeness, calibration across groups, and the harm of applying a miscalibrated tool. Ask what validation in your own patient population would be needed first.